Dignitana AB (DIGN) - Total Assets
Based on the latest financial reports, Dignitana AB (DIGN) holds total assets worth Skr29.09 Million SEK (≈ $3.13 Million USD) as of March 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Dignitana AB - Total Assets Trend (2007–2024)
This chart illustrates how Dignitana AB's total assets have evolved over time, based on quarterly financial data. Also see market value of Dignitana AB for the company's overall valuation and market capitalisation.
Dignitana AB - Asset Composition Analysis
Current Asset Composition (December 2024)
Dignitana AB's total assets of Skr29.09 Million consist of 56.9% current assets and 43.1% non-current assets. Review total liabilities of Dignitana AB to assess the company's total debt and financial obligations.
| Asset Category | Amount (SEK) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Skr0.00 | 8.4% |
| Accounts Receivable | Skr9.27 Million | 26.3% |
| Inventory | Skr7.85 Million | 22.3% |
| Property, Plant & Equipment | Skr0.00 | 0.0% |
| Intangible Assets | Skr266.00K | 0.8% |
| Goodwill | Skr0.00 | 0.0% |
Asset Composition Trend (2007–2024)
This chart illustrates how Dignitana AB's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See Dignitana AB stock quote for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Dignitana AB's current assets represent 56.9% of total assets in 2024, an increase from 0.0% in 2007.
- Cash Position: Cash and equivalents constituted 8.4% of total assets in 2024, down from 18.1% in 2007.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2007.
- Asset Diversification: The largest asset category is accounts receivable at 26.3% of total assets.
Dignitana AB Competitors by Total Assets
Key competitors of Dignitana AB based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
COCHLEAR LTD ADR 1/2/O.N.
F:OC50
|
Germany | €2.83 Billion |
|
TransMedics Group Inc
NASDAQ:TMDX
|
USA | $1.46 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.89 Billion |
|
Novocure Ltd
NASDAQ:NVCR
|
USA | $787.93 Million |
|
Shenzhen New Industries Biomedical
SHE:300832
|
China | CN¥9.58 Billion |
|
Jafron Biomedical Co Ltd
SHE:300529
|
China | CN¥5.20 Billion |
|
Hangzhou AGS MedTech Co. Ltd. A
SHG:688581
|
China | CN¥2.70 Billion |
|
Nanjing Vishee Medical Technology Co Ltd
SHG:688580
|
China | CN¥1.79 Billion |
Dignitana AB - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.78 | 0.61 | 0.75 |
| Quick Ratio | 0.46 | 0.32 | 0.54 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | Skr-4.86 Million | Skr-14.06 Million | Skr-8.43 Million |
Dignitana AB - Advanced Valuation Insights
This section examines the relationship between Dignitana AB's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 40.14 |
| Latest Market Cap to Assets Ratio | 0.53 |
| Asset Growth Rate (YoY) | -21.3% |
| Total Assets | Skr35.28 Million |
| Market Capitalization | $18.55 Million USD |
Valuation Analysis
Below Book Valuation: The market values Dignitana AB's assets below their book value (0.53x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Dignitana AB's assets decreased by 21.3% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Dignitana AB (2007–2024)
The table below shows the annual total assets of Dignitana AB from 2007 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | Skr35.28 Million ≈ $3.80 Million |
-21.30% |
| 2023-12-31 | Skr44.83 Million ≈ $4.82 Million |
-23.43% |
| 2022-12-31 | Skr58.55 Million ≈ $6.30 Million |
-17.94% |
| 2021-12-31 | Skr71.35 Million ≈ $7.68 Million |
-48.25% |
| 2020-12-31 | Skr137.89 Million ≈ $14.84 Million |
+69.21% |
| 2019-12-31 | Skr81.49 Million ≈ $8.77 Million |
+1.39% |
| 2018-12-31 | Skr80.37 Million ≈ $8.65 Million |
-2.34% |
| 2017-12-31 | Skr82.30 Million ≈ $8.86 Million |
+28.92% |
| 2016-12-31 | Skr63.83 Million ≈ $6.87 Million |
+33.99% |
| 2015-12-31 | Skr47.64 Million ≈ $5.13 Million |
+125.54% |
| 2014-12-31 | Skr21.12 Million ≈ $2.27 Million |
-39.73% |
| 2013-12-31 | Skr35.05 Million ≈ $3.77 Million |
+1.01% |
| 2012-12-31 | Skr34.70 Million ≈ $3.73 Million |
+127.52% |
| 2011-12-31 | Skr15.25 Million ≈ $1.64 Million |
-27.53% |
| 2010-12-31 | Skr21.04 Million ≈ $2.26 Million |
+23.89% |
| 2009-12-31 | Skr16.98 Million ≈ $1.83 Million |
+14.26% |
| 2008-12-31 | Skr14.86 Million ≈ $1.60 Million |
+45.98% |
| 2007-12-31 | Skr10.18 Million ≈ $1.10 Million |
-- |
About Dignitana AB
Dignitana AB (publ), a medical technology company, engages in the development, production, and marketing of medical cooling devices in the United States and internationally. It offers DigniCap, a scalp cooling system used to reduce hair loss from chemotherapy treatments, as well as for patients receiving chemotherapy to treat other solid tumors. The company was incorporated in 2007 is headquarter… Read more